Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Total Current Liabilities (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Total Current Liabilities for 16 consecutive years, with $15.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 8.13% to $15.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $15.9 million, a 8.13% increase, with the full-year FY2024 number at $19.5 million, down 2.65% from a year prior.
  • Total Current Liabilities was $15.9 million for Q3 2025 at Gyre Therapeutics, down from $16.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $20.0 million in Q4 2023 to a low of $1.6 million in Q3 2022.
  • A 5-year average of $12.9 million and a median of $14.7 million in 2024 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: tumbled 90.47% in 2022, then surged 725.35% in 2024.
  • Gyre Therapeutics' Total Current Liabilities stood at $14.2 million in 2021, then decreased by 13.58% to $12.2 million in 2022, then surged by 63.76% to $20.0 million in 2023, then fell by 2.65% to $19.5 million in 2024, then dropped by 18.46% to $15.9 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Total Current Liabilities are $15.9 million (Q3 2025), $16.9 million (Q2 2025), and $19.0 million (Q1 2025).